SCHEMBL19934851

SCHEMBL19934851

O=C1c2cc(O)ccc2-c2c(-c3ccc(O)cc3)oc3cc(O)cc1c23

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.51
▸ CYP3A4 P08684 7/20 0.51
▸ MEN1 O00255 6/20 0.51
▸ KMT2A Q03164 6/20 0.51
▸ MAPT P10636 6/20 0.51
▸ CYP2C9 P11712 5/20 0.51
▸ HSD17B10 Q99714 5/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ TP53 P04637 4/20 0.51
▸ HPGD P15428 4/20 0.51
▸ XDH P47989 4/20 0.51
▸ CYP2D6 P10635 4/20 0.51
▸ BACE1 P56817 4/20 0.51
▸ APP P05067 3/20 0.51
▸ ALOX15 P16050 3/20 0.51
▸ CSNK2A2 P19784 3/20 0.51
▸ DAPK1 P53355 3/20 0.51
▸ CSNK2B P67870 3/20 0.51
▸ CSNK2A1 P68400 3/20 0.51
▸ CSNK2A3 Q8NEV1 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929827 0.94 KDM4E (0.51) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19929830 0.92 MIF (0.46) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19929831 0.90 MEN1 (0.51) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19929836 0.85 CYP3A4 (0.57) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL29732709 0.85 CYP3A4 (0.57) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19934850 0.83 CYP1A2 (0.47) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19929835 0.82 CYP3A4 (0.50) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19934849 0.82 CYP3A4 (0.50) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19929832 0.79 CA12 (0.49) KDM4ECYP3A4MEN1KMT2AMAPT
SCHEMBL19929824 0.77 APP (0.56) KDM4ECYP3A4MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-12-17 — — US disclosed
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 KDM4E 3016/4885CYP3A4 717/4885MEN1 157/4885
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them HPGDS, DPP7, DPEP1 KDM4E 3016/4885CYP3A4 717/4885MEN1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback